Mimedx (MDXG) Change in Accured Expenses (2011 - 2026)
Mimedx recorded quarterly Change in Accured Expenses of $250000.0 in Q1 2026, down 92.95% quarter-over-quarter from $3.5 million in Q4 2025, and up 442.47% year-over-year from $46085.9 in Q1 2025.
Mimedx's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $250000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 442.47% year-over-year to $250000.0; the TTM figure through Mar 2026 stood at $2.7 million (up 17.08% YoY), while the FY2025 annual figure was $2.4 million, down 18.13% from the prior year.
- Change in Accured Expenses came in at $250000.0 for Q1 2026 at Mimedx, down from $3.5 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $8.0 million in Q3 2022 to a low of -$6.9 million in Q2 2022.
- A 5-year average of $434470.6 and a median of $522000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 470.84% in 2023 and soared 1472.49% in 2025, its largest moves.
- Mimedx's Change in Accured Expenses stood at $655000.0 in 2022, then tumbled by 470.84% to -$2.4 million in 2023, then surged by 257.55% to $3.8 million in 2024, then dropped by 7.29% to $3.5 million in 2025, then sank by 92.95% to $250000.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $250000.0, $3.5 million, and -$4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 250,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,000.00 |
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2025 | 3.55 Mn |
| Dec 31, 2025 | 3.55 Mn |
| Sep 30, 2025 | -4.71 Mn |
| Sep 30, 2025 | -4.71 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | -73,000.00 |
| Mar 31, 2025 | -73,000.00 |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | -1.68 Mn |
| Sep 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | 229,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Mar 31, 2024 | 522,000.00 |
| Mar 31, 2024 | 522,000.00 |
| Dec 31, 2023 | -2.43 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 637,000.00 |
| Jun 30, 2023 | 637,000.00 |
| Mar 31, 2023 | -398,000.00 |
| Mar 31, 2023 | -398,000.00 |
| Dec 31, 2022 | 655,000.00 |
| Dec 31, 2022 | 655,000.00 |
| Sep 30, 2022 | 8.03 Mn |
| Sep 30, 2022 | 8.03 Mn |
| Jun 30, 2022 | -6.87 Mn |
| Jun 30, 2022 | -6.87 Mn |
| Mar 31, 2022 | 550,000.00 |
| Mar 31, 2022 | 550,000.00 |
| Dec 31, 2021 | -19.66 Mn |
| Dec 31, 2021 | -19.66 Mn |
| Sep 30, 2021 | 12.91 Mn |
| Sep 30, 2021 | 12.91 Mn |
| Jun 30, 2021 | -13.58 Mn |
| Jun 30, 2021 | -13.58 Mn |
| Mar 31, 2021 | -177,000.00 |
| Mar 31, 2021 | -177,000.00 |
| Dec 31, 2020 | 2.38 Mn |
| Dec 31, 2020 | 2.38 Mn |
| Sep 30, 2020 | 7.27 Mn |
| Sep 30, 2020 | 7.27 Mn |
| Jun 30, 2020 | -7.92 Mn |
| Jun 30, 2020 | -7.92 Mn |
| Mar 31, 2020 | -4.19 Mn |
| Mar 31, 2020 | -4.19 Mn |
| Dec 31, 2019 | -5.65 Mn |
| Dec 31, 2019 | -5.65 Mn |
| Sep 30, 2019 | 9.41 Mn |
| Sep 30, 2019 | 9.41 Mn |
| Jun 30, 2019 | 3.69 Mn |
| Jun 30, 2019 | 3.69 Mn |
| Mar 31, 2019 | -7.50 Mn |
| Mar 31, 2019 | -7.50 Mn |
| Dec 31, 2018 | 19.91 Mn |
| Dec 31, 2018 | 19.91 Mn |
| Sep 30, 2018 | -3.30 Mn |
| Sep 30, 2018 | -3.30 Mn |
| Jun 30, 2018 | -399,000.00 |
| Jun 30, 2018 | -399,000.00 |
| Mar 31, 2018 | -134,000.00 |
| Mar 31, 2018 | -134,000.00 |
| Dec 31, 2017 | -6.41 Mn |
| Dec 31, 2017 | -6.41 Mn |
| Sep 30, 2017 | 5.71 Mn |
| Sep 30, 2017 | 5.71 Mn |
| Jun 30, 2017 | -2.22 Mn |
| Jun 30, 2017 | -2.22 Mn |
| Mar 31, 2017 | -618,000.00 |
| Mar 31, 2017 | -618,000.00 |
| Dec 31, 2016 | 13.75 Mn |
| Dec 31, 2016 | 13.75 Mn |
| Sep 30, 2016 | -4.15 Mn |
| Sep 30, 2016 | -4.15 Mn |
| Jun 30, 2016 | -563,000.00 |
| Jun 30, 2016 | -563,000.00 |
| Mar 31, 2016 | 493,000.00 |
| Mar 31, 2016 | 493,000.00 |
| Dec 31, 2015 | 2.04 Mn |
| Dec 31, 2015 | 2.04 Mn |
| Sep 30, 2015 | 2.06 Mn |
| Sep 30, 2015 | 2.06 Mn |
| Jun 30, 2015 | -1.70 Mn |
| Jun 30, 2015 | -1.70 Mn |
| Mar 31, 2015 | 1.11 Mn |
| Mar 31, 2015 | 1.11 Mn |
| Dec 31, 2014 | -318,000.00 |
| Dec 31, 2014 | -318,000.00 |
| Sep 30, 2014 | 18,000.00 |
| Sep 30, 2014 | 18,000.00 |
| Jun 30, 2014 | 603,000.00 |
| Jun 30, 2014 | 603,000.00 |
| Mar 31, 2014 | -37,000.00 |
| Mar 31, 2014 | -37,000.00 |
| Dec 31, 2013 | 1.03 Mn |
| Dec 31, 2013 | 1.03 Mn |
| Sep 30, 2013 | 1.76 Mn |
| Sep 30, 2013 | 1.76 Mn |
| Jun 30, 2013 | -190,426.00 |
| Jun 30, 2013 | -190,426.00 |
| Mar 31, 2013 | 236,788.00 |
| Mar 31, 2013 | 236,788.00 |
| Dec 31, 2012 | -787,016.00 |
| Dec 31, 2012 | -787,016.00 |
| Sep 30, 2012 | 1.27 Mn |
| Sep 30, 2012 | 1.27 Mn |
| Jun 30, 2012 | 15,625.00 |
| Jun 30, 2012 | 15,625.00 |
| Mar 31, 2012 | 103,616.00 |
| Mar 31, 2012 | 103,616.00 |
| Dec 31, 2011 | 204,759.00 |
| Dec 31, 2011 | 204,759.00 |
| Sep 30, 2011 | -47,523.00 |
| Sep 30, 2011 | -47,523.00 |
| Jun 30, 2011 | 31,610.00 |
| Jun 30, 2011 | 31,610.00 |
| Mar 31, 2011 | 6,088.00 |
| Mar 31, 2011 | 6,088.00 |